Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran
- PMID: 33262799
- PMCID: PMC7680520
Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran
Abstract
Background: Following the recent epidemic of coronavirus disease 2019 (COVID-19) in Wuhan, China, a novel betacoronavirus was isolated from two patients in Iran on February 19, 2020. In this study, we aimed to determine the clinical manifestations and outcomes of the first confirmed cases of COVID-19 infection (n=127).
Materials and methods: This prospective study was conducted on all COVID-19-suspected cases, admitted to Masih Daneshvari Hospital (a designated hospital for COVID-19), Tehran, Iran, since February 19, 2020. All patients were tested for COVID-19, using reverse transcription-polymerase chain reaction (RT-PCR) assay. Data of confirmed cases, including demographic characteristics, clinical features, and outcomes, were collected and compared between three groups of patients, requiring different types of admission (requiring ICU admission, admission to the general ward, and transfer to ICU).
Results: Of 412 suspected cases, with the mean age of 54.1 years (SD=13.4), 127 (31%) were positive for COVID-19. Following the patients' first visit to the clinic, 115 cases were admitted to the general ward, while ten patients required ICU admission. Due to clinical deterioration in the condition of 25 patients (out of 115 patients), ICU admission was essential. Based on the results, the baseline characteristics of the groups were similar. Patients requiring ICU admission were more likely to have multiorgan involvement (liver involvement, P<0.001; renal involvement, P<0.001; and cardiac involvement, P=0.02), low O2 saturation (P<0.001), and lymphopenia (P=0.05). During hospital admission, 21 (16.5%) patients died, while the rest (83.5%) were discharged and followed-up until March 26, 2020. Also, the survival rate of patients, who received immunoglobulin, was higher than other patients (60.87% vs. 39.13%).
Conclusion: The mortality rate of COVID-19 patients was considerable in our study. Based on the present results, this infection can cause multiorgan damage. Therefore, intensive monitoring of these patients needs to be considered.
Keywords: COVID-19; Features; ICU; Outcomes.
Copyright© 2020 National Research Institute of Tuberculosis and Lung Disease.
Figures
Similar articles
-
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. JAMA. 2020. PMID: 32250385 Free PMC article.
-
COVID-19 Mortality in Children: A Referral Center Experience from Iran (Mofid Children's Hospital, Tehran, Iran).Can J Infect Dis Med Microbiol. 2022 Mar 16;2022:2737719. doi: 10.1155/2022/2737719. eCollection 2022. Can J Infect Dis Med Microbiol. 2022. PMID: 35340920 Free PMC article.
-
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. JAMA. 2020. PMID: 32031570 Free PMC article.
-
Clinical Features and Outcomes of ICU Patients with COVID-19 Infection in Tehran, Iran: a Single-Centered Retrospective Cohort Study.Tanaffos. 2020 Dec;19(4):300-311. Tanaffos. 2020. PMID: 33959167 Free PMC article.
-
Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.Arch Gynecol Obstet. 2020 Sep;302(3):545-551. doi: 10.1007/s00404-020-05573-8. Epub 2020 Jul 21. Arch Gynecol Obstet. 2020. PMID: 32696241 Free PMC article. Review.
Cited by
-
Identifying COVID-19 by using spectral analysis of cough recordings: a distinctive classification study.Cogn Neurodyn. 2022 Feb;16(1):239-253. doi: 10.1007/s11571-021-09695-w. Epub 2021 Jul 29. Cogn Neurodyn. 2022. PMID: 34341676 Free PMC article.
-
Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study.Front Pharmacol. 2023 Jan 17;13:1107198. doi: 10.3389/fphar.2022.1107198. eCollection 2022. Front Pharmacol. 2023. PMID: 36733376 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Chest CT severity score: assessment of COVID‑19 severity and short-term prognosis in hospitalized Iranian patients.Wien Med Wochenschr. 2022 Mar;172(3-4):77-83. doi: 10.1007/s10354-022-00914-5. Epub 2022 Feb 8. Wien Med Wochenschr. 2022. PMID: 35133531 Free PMC article.
-
Prevalence of the Clinical Symptoms and PCR Test Results on Patients With COVID-19 in South of Tehran.Microbiol Insights. 2022 Jun 19;15:11786361221097680. doi: 10.1177/11786361221097680. eCollection 2022. Microbiol Insights. 2022. PMID: 35903755 Free PMC article.
References
-
- WHO Coronavirus disease (COVID-2019) situation reports. 2020. http://www:who.int/emergencies/diseases/novel-coronavirus-2019/situation... . Accessed 5 Mar 2020. 2020.
-
- Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). 2020. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. - PubMed
-
- Control. CfDCaPI. 2019 Novel coronavirus, Wuhan, China: 2020.
-
- Organisation. WH Home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak. 2020.
LinkOut - more resources
Full Text Sources